Compare RL & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RL | WST |
|---|---|---|
| Founded | 1967 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5B | 17.9B |
| IPO Year | 1997 | 2004 |
| Metric | RL | WST |
|---|---|---|
| Price | $344.33 | $245.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $401.20 | $319.43 |
| AVG Volume (30 Days) | 540.9K | ★ 718.9K |
| Earning Date | 02-05-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.11% | 0.37% |
| EPS Growth | ★ 19.57 | 1.49 |
| EPS | ★ 12.66 | 6.79 |
| Revenue | ★ $7,079,000,000.00 | $2,886,900,000.00 |
| Revenue This Year | $15.92 | $6.73 |
| Revenue Next Year | $5.79 | $6.07 |
| P/E Ratio | ★ $26.08 | $34.94 |
| Revenue Growth | ★ 6.75 | 1.95 |
| 52 Week Low | $176.61 | $187.43 |
| 52 Week High | $387.65 | $322.34 |
| Indicator | RL | WST |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 52.60 |
| Support Level | $322.82 | $241.57 |
| Resistance Level | $379.68 | $251.73 |
| Average True Range (ATR) | 10.81 | 6.91 |
| MACD | -0.31 | 0.60 |
| Stochastic Oscillator | 52.33 | 69.02 |
Founded by designer Ralph Lauren (current executive chairman and chief creative officer) in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.